{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T10:03:12Z","timestamp":1781517792507,"version":"3.54.1"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003621","name":"Ministry of Science, ICT and Future Planning","doi-asserted-by":"publisher","award":["2021R1A2C1004343"],"award-info":[{"award-number":["2021R1A2C1004343"]}],"id":[{"id":"10.13039\/501100003621","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003621","name":"Ministry of Science, ICT and Future Planning","doi-asserted-by":"publisher","award":["2021R1A2C1011142"],"award-info":[{"award-number":["2021R1A2C1011142"]}],"id":[{"id":"10.13039\/501100003621","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.jconrel.2023.12.049","type":"journal-article","created":{"date-parts":[[2024,1,9]],"date-time":"2024-01-09T05:30:32Z","timestamp":1704778232000},"page":"410-424","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Pre-mixing of omega-3 fatty acid-containing liposomes enhances the drug release rate and therapeutic efficacy of anticancer drugs loaded in liposomes"],"prefix":"10.1016","volume":"366","author":[{"given":"Eun-A","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyeon Gyeom","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bao Loc","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su-Jin","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soo-Bin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung Hun","family":"Bae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"So Yeon","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong Oh","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"So Hee","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soo-Jeong","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2023.12.049_bb0005","doi-asserted-by":"crossref","first-page":"16982","DOI":"10.1021\/acsnano.1c04996","article-title":"Lipid nanoparticles from liposomes to mRNA vaccine delivery, a landscape of research diversity and advancement","volume":"15","author":"Tenchov","year":"2021","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2023.12.049_bb0010","first-page":"1","article-title":"Lipid-based nanoparticles for photosensitive drug delivery systems","author":"Shim","year":"2022","journal-title":"J. Pharm. Investig."},{"key":"10.1016\/j.jconrel.2023.12.049_bb0015","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jconrel.2012.03.020","article-title":"Doxil(R)\u2013the first FDA-approved nano-drug: lessons learned","volume":"160","author":"Barenholz","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2023.12.049_bb0020","first-page":"987","article-title":"Prolonged circulation time and enhanced accumulation in malignant exudates of doxorubicin encapsulated in polyethylene-glycol coated liposomes","volume":"54","author":"Gabizon","year":"1994","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2023.12.049_bb0025","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.bbamem.2004.03.006","article-title":"Drug release rate influences the pharmacokinetics, biodistribution, therapeutic activity, and toxicity of pegylated liposomal doxorubicin formulations in murine breast cancer","volume":"1663","author":"Charrois","year":"2004","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jconrel.2023.12.049_bb0030","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s00280-001-0405-3","article-title":"Lack of activity of stealth liposomal doxorubicin in the treatment of patients with anthracycline-resistant breast cancer","volume":"49","author":"Rivera","year":"2002","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.jconrel.2023.12.049_bb0035","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.jconrel.2013.08.034","article-title":"Intact Doxil is taken up intracellularly and released doxorubicin sequesters in the lysosome: evaluated by in vitro\/in vivo live cell imaging","volume":"172","author":"Seynhaeve","year":"2013","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2023.12.049_bb0040","doi-asserted-by":"crossref","first-page":"6944","DOI":"10.1158\/1078-0432.CCR-05-0343","article-title":"Determination of doxorubicin levels in whole tumor and tumor nuclei in murine breast cancer tumors","volume":"11","author":"Laginha","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2023.12.049_bb0045","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jconrel.2019.06.012","article-title":"Heat-activated drug delivery increases tumor accumulation of synergistic chemotherapies","volume":"308","author":"Dunne","year":"2019","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2023.12.049_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.113985","article-title":"Drug development of lyso-thermosensitive liposomal doxorubicin: combining hyperthermia and thermosensitive drug delivery","volume":"178","author":"Borys","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2023.12.049_bb0055","doi-asserted-by":"crossref","first-page":"3877","DOI":"10.1038\/s41467-023-39607-x","article-title":"Ultrasound-responsive low-dose doxorubicin liposomes trigger mitochondrial DNA release and activate cGAS-STING-mediated antitumour immunity","volume":"14","author":"Wang","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2023.12.049_bb0060","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0139752","article-title":"Increased duration of heating boosts local drug deposition during radiofrequency ablation in combination with thermally sensitive liposomes (ThermoDox) in a porcine model","volume":"10","author":"Swenson","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2023.12.049_bb0065","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.3390\/pharmaceutics13081310","article-title":"Mild hyperthermia responsive liposomes for enhanced in vitro and in vivo anticancer efficacy of doxorubicin against hepatocellular carcinoma","volume":"13","author":"Rahim","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2023.12.049_bb0070","doi-asserted-by":"crossref","first-page":"4608","DOI":"10.1016\/j.biomaterials.2012.03.018","article-title":"Pharmacokinetics & tissue distribution of temperature-sensitive liposomal doxorubicin in tumor-bearing mice triggered with mild hyperthermia","volume":"33","author":"Al-Ahmady","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2023.12.049_bb0075","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jconrel.2013.02.026","article-title":"A simple way to enhance Doxil\u00ae therapy: drug release from liposomes at the tumor site by amphiphilic block copolymer","volume":"168","author":"Zhao","year":"2013","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2023.12.049_bb0080","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ejpb.2021.08.013","article-title":"Sequential administration of PEG-span 80 niosome enhances anti-tumor effect of doxorubicin-containing PEG liposome","volume":"169","author":"Minamisakamoto","year":"2021","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2023.12.049_bb0085","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.nano.2011.05.013","article-title":"A comparison of changes to doxorubicin pharmacokinetics, antitumor activity, and toxicity mediated by PEGylated dendrimer and PEGylated liposome drug delivery systems","volume":"8","author":"Kaminskas","year":"2012","journal-title":"Nanomedicine"},{"key":"10.1016\/j.jconrel.2023.12.049_bb0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0009-3084(03)00101-4","article-title":"Docosahexaenoic acid: membrane properties of a unique fatty acid","volume":"126","author":"Stillwell","year":"2003","journal-title":"Chem. Phys. Lipids"},{"key":"10.1016\/j.jconrel.2023.12.049_bb0095","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1080\/07388551.2016.1207153","article-title":"Docosahexaenoic acid: one molecule diverse functions","volume":"37","author":"Hashimoto","year":"2017","journal-title":"Crit. Rev. Biotechnol."},{"key":"10.1016\/j.jconrel.2023.12.049_bb0100","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0005-2736(00)00227-3","article-title":"Docosahexaenoic acid-containing phosphatidylcholine affects the binding of monoclonal antibodies to purified Kb reconstituted into liposomes","volume":"1467","author":"Jenski","year":"2000","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jconrel.2023.12.049_bb0105","doi-asserted-by":"crossref","first-page":"8305","DOI":"10.2147\/IJN.S220053","article-title":"Krill oil-incorporated liposomes as an effective nanovehicle to ameliorate the inflammatory responses of DSS-induced colitis","author":"Kim","year":"2019","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2023.12.049_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2019.115143","article-title":"Chitosan-coated liposomes to stabilize and enhance transdermal delivery of indocyanine green for photodynamic therapy of melanoma","volume":"224","author":"Lee","year":"2019","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.jconrel.2023.12.049_bb0115","first-page":"1","article-title":"Tricaprin as a membrane permeability regulator: sustained small hydrophilic substance release from liposomes","author":"Ro","year":"2023","journal-title":"J. Pharm. Investig."},{"key":"10.1016\/j.jconrel.2023.12.049_bb0120","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0005-2736(95)00159-Z","article-title":"Transmembrane gradient driven phase transitions within vesicles: lessons for drug delivery","volume":"1239","author":"Lasic","year":"1995","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jconrel.2023.12.049_bb0125","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.ijpharm.2018.12.072","article-title":"Effective co-encapsulation of doxorubicin and irinotecan for synergistic therapy using liposomes prepared with triethylammonium sucrose octasulfate as drug trapping agent","volume":"557","author":"Liu","year":"2019","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2023.12.049_bb0130","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1080\/10717544.2016.1272651","article-title":"Irinotecan-encapsulated double-reverse thermosensitive nanocarrier system for rectal administration","volume":"24","author":"Din","year":"2017","journal-title":"Drug Deliv."},{"key":"10.1016\/j.jconrel.2023.12.049_bb0135","first-page":"646","article-title":"Liposome-based intracellular kinetics of doxorubicin in K562\/DOX cells","volume":"63","author":"Xu","year":"2008","journal-title":"Die Pharmazie"},{"key":"10.1016\/j.jconrel.2023.12.049_bb0140","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1007\/s40005-021-00546-8","article-title":"Dose-independent pharmacokinetics of loganin in rats: effect of intestinal first-pass metabolism on bioavailability","volume":"51","author":"Park","year":"2021","journal-title":"J. Pharm. Investig."},{"key":"10.1016\/j.jconrel.2023.12.049_bb0145","doi-asserted-by":"crossref","first-page":"510","DOI":"10.4062\/biomolther.2022.049","article-title":"Effects of dextran sulfate sodium-induced ulcerative colitis on the disposition of tofacitinib in rats","volume":"30","author":"Bae","year":"2022","journal-title":"Biomol. Ther."},{"key":"10.1016\/j.jconrel.2023.12.049_bb0150","first-page":"33","article-title":"A simple and sensitive HPLC method for fluorescence quantitation of doxorubicin in micro-volume plasma: applications to pharmacokinetic studies in rats","volume":"14","author":"Daeihamed","year":"2015","journal-title":"Iran. J. Pharm. Res."},{"key":"10.1016\/j.jconrel.2023.12.049_bb0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0378-5173(94)00414-Z","article-title":"Pharmacokinetics and tissue distribution of adriamycin and adriamycinol after intravenous administration of adriamycin-loaded neutral proliposomes to rats","volume":"121","author":"Lee","year":"1995","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2023.12.049_bb0160","doi-asserted-by":"crossref","DOI":"10.1002\/bdd.2510040213","article-title":"Pharmacokinetics (2nd edn, revised and expanded), M. Gibaldi and D. Perrier (Vol. 15 of Drugs and the pharmaceutical sciences), Marcel Dekker, New York, 1982","volume":"4","author":"DeVane","year":"1983","journal-title":"Biopharm. Drug Dispos."},{"key":"10.1016\/j.jconrel.2023.12.049_bb0165","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/BF01062108","article-title":"Critical evaluation of the potential error in pharmacokinetic studies of using the linear trapezoidal rule method for the calculation of the area under the plasma level-time curve","volume":"6","author":"Chiou","year":"1978","journal-title":"J. Pharmacokinet. Biopharm."},{"key":"10.1016\/j.jconrel.2023.12.049_bb0170","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.colsurfb.2009.03.019","article-title":"Effect of saturation degree on the interactions between fatty acids and phosphatidylcholines in binary and ternary Langmuir monolayers","volume":"72","author":"H\u0105c-Wydro","year":"2009","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.jconrel.2023.12.049_bb0175","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1248\/cpb.c13-00587","article-title":"Thermotropic phase behavior of hydrogenated soybean phosphatidylcholine\u2013cholesterol binary liposome membrane","volume":"62","author":"Kitayama","year":"2014","journal-title":"Chem. Pharm. Bull."},{"key":"10.1016\/j.jconrel.2023.12.049_bb0180","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1016\/j.bbamem.2011.04.006","article-title":"Mechanics and dynamics of triglyceride-phospholipid model membranes: implications for cellular properties and function","volume":"1808","author":"Pakkanen","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jconrel.2023.12.049_bb0185","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.ejpb.2016.04.011","article-title":"Insights into composition\/structure\/function relationships of Doxil\u00ae gained from \u201chigh-sensitivity\u201d differential scanning calorimetry","volume":"104","author":"Wei","year":"2016","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2023.12.049_bb0190","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0005-2736(98)00175-8","article-title":"Doxorubicin physical state in solution and inside liposomes loaded via a pH gradient","volume":"1415","author":"Li","year":"1998","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jconrel.2023.12.049_bb0195","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1002\/ejlt.201100050","article-title":"Lipids, curvature, and nano-medicine","volume":"113","author":"Mouritsen","year":"2011","journal-title":"Eur. J. Lipid Sci. Technol."},{"key":"10.1016\/j.jconrel.2023.12.049_bb0200","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.plipres.2012.09.002","article-title":"Membrane-perturbing effect of fatty acids and lysolipids","volume":"52","author":"Arouri","year":"2013","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.jconrel.2023.12.049_bb0205","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1007\/s11095-013-1290-2","article-title":"Novel nanostructured lipid carrier co-loaded with doxorubicin and docosahexaenoic acid demonstrates enhanced in vitro activity and overcomes drug resistance in MCF-7\/Adr cells","volume":"31","author":"Mussi","year":"2014","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2023.12.049_bb0210","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1096\/fj.10-163709","article-title":"Enriching lipid nanovesicles with short-chain glucosylceramide improves doxorubicin delivery and efficacy in solid tumors","volume":"25","author":"van Lummel","year":"2011","journal-title":"FASEB J."},{"key":"10.1016\/j.jconrel.2023.12.049_bb0215","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.addr.2015.09.012","article-title":"PEGylation as a strategy for improving nanoparticle-based drug and gene delivery","volume":"99","author":"Suk","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2023.12.049_bb0220","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.addr.2016.01.022","article-title":"The role of helper lipids in lipid nanoparticles (LNPs) designed for oligonucleotide delivery","volume":"99","author":"Cheng","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2023.12.049_bb0225","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.3390\/pharmaceutics14071372","article-title":"Nanomaterial-based drug delivery system targeting lymph nodes","volume":"14","author":"Cheng","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2023.12.049_bb0230","first-page":"693","article-title":"Visualization of bioavailable liposomal doxorubicin using a non-perturbing confocal imaging technique","volume":"16","author":"Krishna","year":"2001","journal-title":"Histol. Histopathol."},{"key":"10.1016\/j.jconrel.2023.12.049_bb0235","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1016\/j.nano.2015.06.007","article-title":"In vitro experiments showing enhanced release of doxorubicin from Doxil\u00ae in the presence of ammonia may explain drug release at tumor site","volume":"11","author":"Silverman","year":"2015","journal-title":"Nanomedicine"},{"key":"10.1016\/j.jconrel.2023.12.049_bb0240","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0185654","article-title":"Comparison of the adverse event profiles of conventional and liposomal formulations of doxorubicin using the FDA adverse event reporting system","volume":"12","author":"Fukuda","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2023.12.049_bb0245","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1097\/00001813-199911000-00007","article-title":"Pharmacological studies of cisplatin encapsulated in long-circulating liposomes in mouse tumor models","volume":"10","author":"Bandak","year":"1999","journal-title":"Anti-Cancer Drugs"},{"key":"10.1016\/j.jconrel.2023.12.049_bb0250","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jconrel.2009.03.007","article-title":"Ultrasound triggered release of cisplatin from liposomes in murine tumors","volume":"137","author":"Schroeder","year":"2009","journal-title":"J. Control. Release"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365923008337?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365923008337?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T21:32:00Z","timestamp":1738099920000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365923008337"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":50,"alternative-id":["S0168365923008337"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2023.12.049","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pre-mixing of omega-3 fatty acid-containing liposomes enhances the drug release rate and therapeutic efficacy of anticancer drugs loaded in liposomes","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2023.12.049","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}